ITCI

Intra-Cellular Therapies, Inc.

No insider bought or sold Intra-Cellular Therapies, Inc. in the last 12 months

$0Bought, 12 mo

$0Sold, 12 mo

Follow ITCI

ITCI over the last year

Prices for ITCI aren't in yet.

ITCI after insider buys

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Congress

Members reported 6 trades in ITCI since 2024.

Every filing

155 insider filings since 2016, newest first

ITCISell

Michael Halstead · President

$3.7M−100.0%Nov 14

ITCISell

Sharon Mates · Chair and CEO

$5.1M−6.0%Aug 30

ITCISell

Sharon Mates · Chair and CEO

$7.1M−8.0%Aug 28

ITCISell

Sharon Mates · Chair and CEO

$9.1M−10.0%Aug 23

ITCISell

Mark Neumann · EVP and Chief Commercial Officer

$1.4M−39.0%Aug 20

ITCISell

Rory B Riggs · Director

$337K−4.0%Jun 25

ITCISell

Nostrand Robert L Van · Director

$1.5M−67.0%Jun 21

ITCISell

Sharon Mates · Chair, President and CEO

$4.0M−6.0%Mar 11

ITCISell

Lawrence J. Hineline · SVP of Finance, CFO

$1.5M−100.0%Mar 11

ITCISell

Michael Halstead · EVP and General Counsel

$1.4M−100.0%Mar 11

ITCISell

Mark Neumann · EVP and Chief Commercial Officer

$1.4M−41.0%Mar 11

ITCISell

Suresh K. Durgam · EVP and Chief Medical Officer

$673K−34.0%Mar 11

ITCISell

Nostrand Robert L Van · Director

$1.5M−68.0%Feb 28

ITCISell

Sharon Mates · Chair, President and CEO

$1.6M−2.0%Feb 27

ITCISell

Joel S Marcus · Director

$1.8M−35.0%Feb 27

ITCISell

Michael Halstead · EVP and General Counsel

$550K−100.0%Feb 27

ITCISell

Lawrence J. Hineline · SVP of Finance, CFO

$926K−100.0%Feb 27

ITCISell

Suresh K. Durgam · EVP and Chief Medical Officer

$289K−30.0%Feb 27

ITCISell

Mark Neumann · EVP and Chief Commercial Officer

$554K−21.0%Feb 27

ITCISell

Sharon Mates · Chair, President and CEO

$2.3M−3.0%Feb 5

ITCISell

Michael Halstead · EVP and General Counsel

$788K−100.0%Feb 5

ITCISell

Mark Neumann · EVP and Chief Commercial Officer

$796K−29.0%Feb 5

ITCISell

Lawrence J. Hineline · SVP of Finance, CFO

$745K−100.0%Feb 5

ITCISell

Suresh K. Durgam · EVP and Chief Medical Officer

$414K−52.0%Feb 5

ITCISell

Sharon Mates · Chair, President and CEO

$12.7M−15.0%Jan 18

ITCISell

Michael Halstead · EVP and General Counsel

$3.3M−100.0%Jan 12

ITCISell

Suresh K. Durgam · EVP and Chief Medical Officer

$4.4M−100.0%Jan 4

ITCISell

Suresh K. Durgam · EVP and Chief Medical Officer

$1.4M−100.0%Dec 15

ITCISell

Mark Neumann · EVP and Chief Commercial Officer

$2.4M−59.0%Nov 8

ITCISell

Sharon Mates · Chair, President and CEO

$5.4M−9.0%Sep 19

ITCISell

Mark Neumann · EVP and Chief Commercial Officer

$3.3M−55.0%Aug 9

ITCISell

Suresh K. Durgam · EVP and Chief Medical Officer

$120K−8.0%Jul 20

ITCISell

Lawrence J. Hineline · SVP of Finance CFO

$5.2M−100.0%Jun 16

ITCISell

Nostrand Robert L Van · Director

$630K−52.0%Apr 19

ITCISell

Mark Neumann · EVP and Chief Commercial Officer

$847K−26.0%Mar 30

ITCISell

Sharon Mates · Chair, President and CEO

$2.7M−5.0%Mar 13

ITCISell

Suresh K. Durgam · EVP and Chief Medical Officer

$331K−24.0%Mar 13

ITCISell

Mark Neumann · EVP and Chief Commercial Officer

$540K−17.0%Mar 13

ITCISell

Michael Halstead · EVP and General Counsel

$1.1M−100.0%Mar 13

ITCISell

Lawrence J. Hineline · SVP of Finance CFO

$925K−100.0%Mar 13

ITCISell

Mark Neumann · EVP and Chief Commercial Officer

$362K−13.0%Mar 3

ITCISell

Sharon Mates · Chair, President and CEO

$1.1M−2.0%Feb 27

ITCISell

Mark Neumann · EVP and Chief Commercial Officer

$191K−7.0%Feb 27

ITCISell

Suresh K. Durgam · SVP and Chief Medical Officer

$373K−25.0%Feb 27

ITCISell

Michael Halstead · EVP and General Counsel

$372K−100.0%Feb 27

ITCISell

Lawrence J. Hineline · SVP of Finance CFO

$351K−100.0%Feb 27

ITCISell

Sharon Mates · Chair, President and CEO

$1.3M−2.0%Feb 22

ITCISell

Mark Neumann · EVP and Chief Commercial Officer

$183K−7.0%Feb 22

ITCISell

Suresh K. Durgam · SVP and Chief Medical Officer

$391K−27.0%Feb 22

ITCISell

Michael Halstead · EVP and General Counsel

$522K−100.0%Feb 22

Older filings

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.